Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Rtt att invnda: Du har rtt att invnda mot behandling som baseras p berttigat intresse
Developed by Eli Lilly under the compound code LY3437943, retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors a mechanism that distinguishes it from currently approved agents such as semaglutide and tirzepatide
Common: nausea (especially during dose increasesusually mild and transient), constipation or diarrhea, occasional vomiting, fatigue in first weeks, decreased appetite (the desired effect, but worth noting)
, L-
Insufficient sample size to report among uninsured adults who have ever taken these drugs
US$ 28.14
US$ 27.95
US$ 24.88
US$ 23.23
US$ 21.32
US$ 28.93
US$ 22.41
